MORE VIDEOS
Istražite više
Rak dojke

Sljedeći

Auto Play
Amyloidosis - Rare Disease Day 2011 My Story
00:04:28
Amyloidosis - Rare Disease Day 2011 My Story
5 Pogledi . 11/23/23 administrator
Targeting β-amyloid and tau in Alzheimer's disease
00:03:11
Targeting β-amyloid and tau in Alzheimer's disease
3 Pogledi . 11/23/23 administrator
Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
00:02:30
Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
6 Pogledi . 11/23/23 administrator
Does Ovarian Cancer Start in the Fallopian Tubes? February 8, 2011
01:15:45
Does Ovarian Cancer Start in the Fallopian Tubes? February 8, 2011
4 Pogledi . 09/10/23 administrator
Green Laning Devon - DTRF Teign to Tamar April 2011 Part 2
00:11:42
Green Laning Devon - DTRF Teign to Tamar April 2011 Part 2
6 Pogledi . 09/10/23 administrator
DTRF @ BMAD 2011
00:02:03
DTRF @ BMAD 2011
3 Pogledi . 09/10/23 administrator
Childhood Cancer (Ewing Sarcoma)- The Seany Foundation 2011
00:05:45
Childhood Cancer (Ewing Sarcoma)- The Seany Foundation 2011
5 Pogledi . 09/10/23 administrator
STEAP1 targeting CAR-T therapy for solid tumors
00:02:17
STEAP1 targeting CAR-T therapy for solid tumors
0 Pogledi . 09/10/23 administrator
STEAP1 targeting CAR-T therapy for solid tumors
00:02:17
STEAP1 targeting CAR-T therapy for solid tumors
3 Pogledi . 09/10/23 administrator
Patient Perspective and Dr. Sardi (part 1) June 2011 PMP Symposium
00:29:54
Patient Perspective and Dr. Sardi (part 1) June 2011 PMP Symposium
2 Pogledi . 09/10/23 administrator
Intro and Dr. Sugarbaker (part 1) June 2011 PMP Symposium
00:29:29
Intro and Dr. Sugarbaker (part 1) June 2011 PMP Symposium
3 Pogledi . 09/10/23 administrator
2020 Targeting ALK - From Discovery to Frontline Treatment
00:45:52
2020 Targeting ALK - From Discovery to Frontline Treatment
6 Pogledi . 07/30/23 administrator
Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
00:39:36
Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Pogledi . 07/30/23 administrator
Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
00:01:10
Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
3 Pogledi . 07/30/23 administrator
Rural Doctors Broadcasts Dermatology: Skin Cancer September 2011
00:59:21
Rural Doctors Broadcasts Dermatology: Skin Cancer September 2011
4 Pogledi . 07/30/23 administrator
Melanoma 2011 and Beyond
00:28:00
Melanoma 2011 and Beyond
13 Pogledi . 07/30/23 administrator
Study: New immunotherapy shows promise in targeting pancreatic cancer tumors
00:01:23
Study: New immunotherapy shows promise in targeting pancreatic cancer tumors
6 Pogledi . 07/30/23 administrator
Targeting chronic inflammation in MPNs
00:02:26
Targeting chronic inflammation in MPNs
3 Pogledi . 07/29/23 administrator
FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More
00:06:58
FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More
1 Pogledi . 07/18/23 administrator

Targeting of NSCLC in 2011

3 Pogledi • 07/30/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Targeting of NSCLC in 2011

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play

Amyloidosis - Rare Disease Day 2011 My Story
00:04:28
Amyloidosis - Rare Disease Day 2011 My Story
5 Pogledi . 11/23/23 administrator
Targeting β-amyloid and tau in Alzheimer's disease
00:03:11
Targeting β-amyloid and tau in Alzheimer's disease
3 Pogledi . 11/23/23 administrator
Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
00:02:30
Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
6 Pogledi . 11/23/23 administrator
Does Ovarian Cancer Start in the Fallopian Tubes? February 8, 2011
01:15:45
Does Ovarian Cancer Start in the Fallopian Tubes? February 8, 2011
4 Pogledi . 09/10/23 administrator
Green Laning Devon - DTRF Teign to Tamar April 2011 Part 2
00:11:42
Green Laning Devon - DTRF Teign to Tamar April 2011 Part 2
6 Pogledi . 09/10/23 administrator
DTRF @ BMAD 2011
00:02:03
DTRF @ BMAD 2011
3 Pogledi . 09/10/23 administrator
Childhood Cancer (Ewing Sarcoma)- The Seany Foundation 2011
00:05:45
Childhood Cancer (Ewing Sarcoma)- The Seany Foundation 2011
5 Pogledi . 09/10/23 administrator
STEAP1 targeting CAR-T therapy for solid tumors
00:02:17
STEAP1 targeting CAR-T therapy for solid tumors
0 Pogledi . 09/10/23 administrator
STEAP1 targeting CAR-T therapy for solid tumors
00:02:17
STEAP1 targeting CAR-T therapy for solid tumors
3 Pogledi . 09/10/23 administrator
Patient Perspective and Dr. Sardi (part 1) June 2011 PMP Symposium
00:29:54
Patient Perspective and Dr. Sardi (part 1) June 2011 PMP Symposium
2 Pogledi . 09/10/23 administrator
Intro and Dr. Sugarbaker (part 1) June 2011 PMP Symposium
00:29:29
Intro and Dr. Sugarbaker (part 1) June 2011 PMP Symposium
3 Pogledi . 09/10/23 administrator
2020 Targeting ALK - From Discovery to Frontline Treatment
00:45:52
2020 Targeting ALK - From Discovery to Frontline Treatment
6 Pogledi . 07/30/23 administrator
Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
00:39:36
Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Pogledi . 07/30/23 administrator
Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
00:01:10
Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
3 Pogledi . 07/30/23 administrator
Rural Doctors Broadcasts Dermatology: Skin Cancer September 2011
00:59:21
Rural Doctors Broadcasts Dermatology: Skin Cancer September 2011
4 Pogledi . 07/30/23 administrator
Melanoma 2011 and Beyond
00:28:00
Melanoma 2011 and Beyond
13 Pogledi . 07/30/23 administrator
Study: New immunotherapy shows promise in targeting pancreatic cancer tumors
00:01:23
Study: New immunotherapy shows promise in targeting pancreatic cancer tumors
6 Pogledi . 07/30/23 administrator
Targeting chronic inflammation in MPNs
00:02:26
Targeting chronic inflammation in MPNs
3 Pogledi . 07/29/23 administrator
FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More
00:06:58
FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More
1 Pogledi . 07/18/23 administrator